BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, May 8, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 17, 2014
View Archived Issues
BioMarin Pharmaceutical designs new agent for mucopolysaccharidosis type IIIB
Read More
Novel proteasome inhibitor discovered by Vivolux
Read More
Gliknik patents novel stradobodies
Read More
U.S. researchers prepare new MAbs for diagnostic and treatment of cancer
Read More
Japanese investigators isolate new agents for cancer
Read More
Islet Sciences to acquire BHV Pharma, remogliflozin etabonate
Read More
Researchers at Chugai Pharmaceutical present novel antibodies
Read More
Tesaro and AnaptysBio establish immuno-oncology antibody collaboration
Read More
Early Access to Medicines and Promising Innovative Medicine schemes to be introduced in the U.K.
Read More
Dose-related efficacy seen with house dust mite allergy immunotherapy tablet MK-8237
Read More
Potent, pangenomic activity for ABT-493 and ABT-530 reported
Read More
Regenerative Sciences' Regenexx-SD stem cell therapy studied for knee osteoarthritis
Read More
Results from phase III COPD studies comparing Anoro Ellipta with Advair Diskus and Seretide Diskus
Read More
Japanese approval for Poteligeo in PTCL and CTCL
Read More
GLPG-0187 shows a favorable toxicity profile in phase I trials in patients with solid tumors
Read More
Edison's EPI-743 begins trial in Pearson syndrome, receives fast track designation
Read More
Primary endpoint met in POISE trial of obeticholic acid in primary biliary cirrhosis
Read More
FDA approves intravenous formulation of Noxafil
Read More
FDA approves Eliquis to prevent DVT following hip or knee replacement surgery
Read More
Daiichi Sankyo seeks Japanese approval of methylene blue for methemoglobinemia
Read More
VG Life Sciences gives update on phase I study of HCQ in combination with sorafenib
Read More
Novel spirocyclic diamine derivatives with activity in animal models of CKD
Read More
Novartis' Afinitor approved in additional indication in Japan
Read More
Fujifilm initiates Japanese phase I study of a radiopharmaceutical diagnostic for prostate cancer
Read More
GW Pharmaceuticals updates progress of cannabinoid programs
Read More
New grant supports Karo Bio's preclinical development of ER-beta agonist
Read More
